Dr. Rony Avritscher, MD

Dr. Avritscher practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Avritscher's NPI, 1124004718, was assigned on December 16, 2005. Dr. Avritscher graduated from Universidade de Sao Paulo Faculty of Medicine in 1995. Dr. Avritscher holds Texas license L9080.

Dr. Avritscher's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Avritscher's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Avritscher practices. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Avritscher's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Avritscher is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Avritscher's licenses on file in 15 states: Texas, California, Maine, Oregon, Oklahoma, New Mexico, Delaware, Massachusetts, Washington, Arizona, Iowa, Illinois, Kentucky, Michigan and Montana.

CMS data shows 262 Medicare services from Dr. Avritscher across 10 procedure codes in 2024, for 127 Medicare patients. Medicare paid $15,147 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 127 Medicare patients who saw Dr. Avritscher in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Avritscher's median patient age at 69, with 39% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Avritscher for performance year 2024, reported as part of a group. Dr. Avritscher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Avritscher as offering telehealth.

Dmand AI links 81 papers to Dr. Avritscher, published from 2009 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Liver Neoplasms, Carcinoma, Hepatocellular and Embolization, Therapeutic. Dr. Avritscher has published most often in J Vasc Interv Radiol. Dr. Avritscher's most frequent co-authors are Bruno Calazans Odisio, MD, Armeen Mahvash, MD and Ravi Murthy, MD.

Dmand AI links Dr. Avritscher to 1 clinical trial. Conditions studied include Neuroendocrine Tumors and Neuroectodermal Tumors.

CMS Open Payments shows 85 general payments to Dr. Avritscher from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Guerbet LLC paid the most, $28,863.

Dr. Avritscher graduated from Universidade de Sao Paulo Faculty of Medicine in 1995.

Dr. Avritscher is in network with 4 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.